(Hypertension. 1997;29:1078-1082.)
© 1997 American Heart Association, Inc.
Articles |
Association of the Angiotensinogen Gene to Serum Angiotensinogen in Blacks and Whites
From the Departments of Medicine and Medical and Molecular Genetics, Indiana University School of Medicine, and the VA Hospital, Indianapolis; and the Marshfield (Wis) Medical Research Foundation (D.A.T.).
Correspondence to J. Howard Pratt, MD, Indiana University Medical Center, 541 Clinical Dr, Indianapolis, IN 46202-5111. E-mail howardp{at}medicine.dmed.iupui.edu
Abstract A variant of the angiotensinogen gene (AGT) that encodes for threonine at codon 235 (T235) has been associated with a higher serum angiotensinogen concentration and with hypertension in white subjects. The frequency of T235 is about two times higher in blacks than whites, suggesting that AGT may contribute to the susceptibility to hypertension in blacks more than it does in whites. However, an association of T235 with angiotensinogen level or blood pressure has not been observed in blacks, possibly because the high prevalence of T235 makes it insufficiently informative as a marker. For this reason, we undertook to further differentiate the T235 carrier state by constructing haplotypes with alleles in the 5' upstream region of AGT. One such haplotype, -1074t;T235, showed a significant association with angiotensinogen level in a cohort of black and white children and adolescents (76 blacks, mean age= 12.3±2.0 [SD] years; 139 whites, mean age=12.4±1.8 years). With a linear regression model, the level of serum angiotensinogen was significantly related to body mass index (P=.0017) and the haplotype (P=.0001). Within specific race groups, the haplotype was significantly related to serum angiotensinogen in both the blacks (P=.0277) and whites (P=.0001). The mean level of angiotensinogen was higher in the blacks carrying a single copy of the haplotype than in those without the haplotype (1472.2±68.4 versus 1274.9±46.7 nmol angiotensin I/L), a difference that was marginally significant (P=.0609). In the whites, the level of angiotensinogen was also higher in carriers of a single copy than in those with no copy (1527.9±71.2 versus 1099.2±20.1 nmol angiotensin I/L) (P=.0003). Serum angiotensinogen level did not increase with two copies of the haplotype, but in each racial group, there were only four individuals who were homozygous. The haplotype showed a marginally significant relation (P=.0757) to the mean of longitudinally determined diastolic pressures adjusted for body mass index, race, sex, and age. In summary, using a haplotype to differentiate further the T235 carrier state, we observed an association of genotype with serum angiotensinogen level and blood pressure in blacks and whites. The findings suggest that AGT may play an important role in blood pressure regulation in both racial groups.
Key Words: angiotensinogen • race • angiotensinogen genes • haplotypes • blood pressure
This article has been cited by other articles:
 |
|
 |
|
  S. Jain, G. Vinukonda, S. N. Fiering, and A. Kumar A haplotype of human angiotensinogen gene containing -217A increases blood pressure in transgenic mice compared with -217G Am J Physiol Regulatory Integrative Comp Physiol, December 1, 2008; 295(6): R1849 - R1857. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. R Conlin Genes and environment in blood pressure control--salt intake again shows its importance Am. J. Clinical Nutrition, August 1, 2008; 88(2): 255 - 256. [Full Text] [PDF]
|
|
|
|
|
|
T. Norat, R. Bowman, R. Luben, A. Welch, K. T. Khaw, N. Wareham, and S. Bingham Blood pressure and interactions between the angiotensin polymorphism AGT M235T and sodium intake: a cross-sectional population study Am. J. Clinical Nutrition, August 1, 2008; 88(2): 392 - 397. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Jain, X. Tang, C. S. Narayanan, Y. Agarwal, S. M. Peterson, C. D. Brown, J. Ott, and A. Kumar Angiotensinogen Gene Polymorphism at -217 Affects Basal Promoter Activity and Is Associated with Hypertension in African-Americans J. Biol. Chem., September 20, 2002; 277(39): 36889 - 36896. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. Rankinen, J. Gagnon, L. Perusse, Y. C. Chagnon, T. Rice, A. S. Leon, J. S. Skinner, J. H. Wilmore, D. C. Rao, and C. Bouchard AGT M235T and ACE ID polymorphisms and exercise blood pressure in the HERITAGE Family Study Am J Physiol Heart Circ Physiol, July 1, 2000; 279(1): H368 - H374. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 F. Paillard, D. Chansel, E. Brand, A. Benetos, F. Thomas, S. Czekalski, R. Ardaillou, and F. Soubrier Genotype-Phenotype Relationships for the Renin-Angiotensin-Aldosterone System in a Normal Population Hypertension, September 1, 1999; 34(3): 423 - 429. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. Corvol, A. Persu, A.-P. Gimenez-Roqueplo, and X. Jeunemaitre Seven Lessons From Two Candidate Genes in Human Essential Hypertension : Angiotensinogen and Epithelial Sodium Channel Hypertension, June 1, 1999; 33(6): 1324 - 1331. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. H. Pratt, W. T. Ambrosius, D. A. Tewksbury, M. A. Wagner, L. Zhou, and M. P. Hanna Serum Angiotensinogen Concentration in Relation to Gonadal Hormones, Body Size, and Genotype in Growing Young People Hypertension, November 1, 1998; 32(5): 875 - 879. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. Corvol and X. Jeunemaitre Molecular Genetics of Human Hypertension: Role of Angiotensinogen Endocr. Rev., October 1, 1997; 18(5): 662 - 677. [Abstract] [Full Text]
|
|